Veterinary Renal Disease Market Report 2026

Veterinary Renal Disease Market Overview

• Veterinary Renal Disease market size has reached to $16.59 billion in 2025 • Expected to grow to $22.42 billion in 2030 at a compound annual growth rate (CAGR) of 6% • Growth Driver: Increasing Pet Ownership Fuels Growth In The Veterinary Renal Disease Market • Market Trend: Launch Of First Diagnostic Test For Early Detection Of Kidney Injury In Pets • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Veterinary Renal Disease Market?

Veterinary renal disease refers to a range of conditions that affect the kidneys of animals, leading to impaired kidney function. It disrupts the kidneys' ability to filter waste, balance fluids, and produce certain hormones, leading to various health issues. The main types of veterinary renal disease are diagnosis and treatment. A diagnosis is a conclusion reached through medical evaluation, identifying a specific condition or disease affecting an individual's health. The animal types are canine, feline, bovine, equine, and others and the indications include renal failure, chronic kidney disease (CKD), renal cystitis, kidney stones, nephritis, and others. The route of administration is injectable and oral and distribution channels are pharmacies, pet specialty stores, e-commerce, and others.

What Is The Veterinary Renal Disease Market Growth Forecast?

The veterinary renal disease market size is expected to see strong growth in the next few years. It will grow to $22.42 billion in 2030 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to advancements in renal diagnostics and imaging, rising adoption of preventive screening programs, development of targeted renal medications, increasing availability of veterinary dialysis services, growing awareness of chronic kidney disease management. Major trends in the forecast period include rising prevalence of chronic kidney disease in companion animals, increasing focus on early diagnosis and routine renal screening, growing adoption of long-term renal management therapies, expansion of specialized renal treatment and dialysis services, emphasis on nutritional and supportive care for renal health.

Global Veterinary Renal Disease Market Segmentation

1) By Type: Diagnosis, Treatment 2) By Animal Type: Canine, Feline, Bovine, Equine, Other Animal Types 3) By Indication: Renal Failure, Chronic Kidney Disease (Ckd), Renal Cystitis, Kidney Stones, Nephritis, Other Indications 4) By Route Of Administration: Injectable, Oral 5) By Distribution Channel: Pharmacies, Pet Specialty Stores, E-Commerce, Other Distribution Channels Subsegments: 1) By Diagnosis: Blood Tests, Urine Tests, Imaging, Biopsy 2) By Treatment: Medications, Dialysis, Kidney Transplantation, Fluid Therapy

What Is The Driver Of The Veterinary Renal Disease Market?

The increasing pet ownership is expected to propel the growth of the veterinary renal disease market going forward. Veterinary renal disease refers to conditions affecting the kidneys in animals, leading to impaired kidney function and potentially resulting in symptoms such as increased thirst, frequent urination, loss of appetite, and weight loss. The increasing veterinary renal disease is driven by longer pet lifespans, exposure to environmental toxins, dietary factors, and genetic predispositions. Veterinary renal disease treatments for pets typically involve dietary management, medication, and fluid therapy to alleviate symptoms, slow disease progression, and improve quality of life. For instance, in April 2025, according to the Canadian Animal Health Institute, a Canada-based trade association, in 2024, Canada was home to an estimated 7.2 million dogs and 8.2 million cats, making pets an integral part of more than half of Canadian households. Therefore, increasing pet ownership is driving the growth of the veterinary renal disease industry.

Key Players In The Global Veterinary Renal Disease Market

Major companies operating in the veterinary renal disease market are Bayer HealthCare Animal Health Inc., Nestlé Purina PetCare Company, Zoetis Inc., Boehringer Ingelheim, Covetrus Inc., Elanco Animal Health Incorporated, Hill's Pet Nutrition Inc., IDEXX Laboratories Inc., Ceva Santé Animale S.A., Dechra Pharmaceuticals PLC, Neogen Corporation, Vetoquinol S.A., Norbrook Laboratories Limited, Nutramax Laboratories Veterinary Sciences Inc., Animalcare Group plc, Antech Diagnostics Inc., Kindred Biosciences Inc., Vedco Inc., MSD Animal Health, Veterinary Transplant Services Inc., Kibow Biotech Inc.

Global Veterinary Renal Disease Market Trends and Insights

Major companies operating in the veterinary renal disease market are focusing on developing technical advancements in treatment and diagnosis, such as novel diagnostic tests with the ability to detect kidney injury even when clinical signs may not be apparent. Diagnostic tests capable of detecting kidney injury with an aim to identify subtle changes in renal function or structure, facilitating early intervention to prevent progression to advanced stages of renal dysfunction. For instance, in June 2023, IDEXX Laboratories Inc., a US-based developer and manufacturer of veterinary products and services, launched the first veterinary diagnostic test for detecting kidney injury in cats and dogs. This test, known as the IDEXX Cystatin B Test, is designed to help veterinarians identify kidney injury before changes in kidney function become apparent, ultimately leading to better patient outcomes. The IDEXX Cystatin B Test will be integrated into test panels that assess renal health, providing valuable insights during an estimated two million patient visits annually.

What Are Latest Mergers And Acquisitions In The Veterinary Renal Disease Market?

In June 2023, Mars Incorporated, a US-based diversified food and pet care technology company, acquired Heska Corporation for approximately $1.3 billion. With this acquisition, Mars aimed to expand and enhance its pet health and veterinary diagnostics capabilities by broadening access to advanced diagnostic technologies, accelerating R&D innovation, and serving a larger global base of veterinary professionals and pets. Heska Corporation is a US-based healthcare technology company that specializes in providing advanced veterinary diagnostic and specialty products and solutions.

Regional Outlook

North America was the largest region in the veterinary renal disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Veterinary Renal Disease Market?

The veterinary renal disease market consists of revenues earned by entities by providing services such as laboratory testing, imaging services, and fluid therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary renal disease market also includes sales of angiotensin receptor blockers, phosphate binders, omega-3 fatty acids, and antioxidants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.